Broadcast Date: June 10, 2024
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Liquid biopsy research is a promising field of study that can potentially revolutionize the way we detect, diagnose, and treat diseases. Access to relevant specimens is an essential part of any discovery and development research program, but the complexity and cost associated with procuring these samples can be daunting. While no universal standard for liquid biopsy bio-banking exists, there are known collection conditions that can influence analytical variability and reduce the risk of failure rates.
Further, validation of molecular biomarkers requires access to a heterogeneous cohort of disease state and control donor to support clinical utility. To unlock the full potential of liquid biopsy research, it is important to have standardized collection protocols and a diverse donor base to develop more accurate models that will translate to better decisions in healthcare.
In this Inside Precision Medicine webinar, Dr. Courtney Noah will discuss the importance of standardized protocols for liquid biopsy collection as well as the need for greater diversity of samples in biobanks. During the webinar, she will cover:
- Best practices for liquid biopsy experimental design and how biobanks can ensure successful outcomes.
- Considerations for specimens’ collections to minimize pre-analytical variability.
- Importance of a diverse donor base to comprehensively investigate molecular biomarkers.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
VP, Scientific Affairs
BioIVT
